- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
|Stem cells attached to biocompatible nanoparticles can be visualised by MRI after transplantation into spinal cord slices.|
Neural stem cells are a promising treatment for repairing spinal cord injuries as they have the ability to generate tissue, but there is no effective way of monitoring the cells for long periods of time after transplantation.
Nguyen TK Thanh at the Davy Faraday Research Laboratory, University College London, LCN and the Royal Institution, and colleagues, believe they have the answer. They have developed hollow biocompatible cobalt-platinum nanoparticles and attached them to the stem cells. The nanoparticles are stable for months and have a high magnetic moment - tendency to align with a magnetic field - so that low concentrations can be detected using magnetic resonance imaging (MRI).
'Magnetic nanoparticles are emerging as novel contrast and tracking agents in medical imaging,' says Samir Pal at the California Institute of Technology, US, an expert in biological-nanoparticle interactions. 'When used as a contrast agent for MRI, the nanoparticles allow researchers and clinicians to enhance the tissue contrast of an area of interest by increasing the relaxation rate of water.'
The team labelled stem cells with their nanoparticles, injected them into spinal cord slices and took images of their progress over time. They found that low numbers of the nanoparticle-loaded stem cells could still be detected two weeks after transplantation. 'The new method demonstrates the feasibility of reliable, noninvasive MRI imaging of nanoparticle-labelled cells,' says Thanh.
Thanh hopes that her stem cell tracking method will be used during stem cell replacement therapy for many central nervous system diseases. Her team is working towards developing nanoparticles that can be used to diagnose and treat these diseases.
About London Centre for Nanotechnology
The London Centre for Nanotechnology is a UK-based multidisciplinary enterprise operating at the forefront of science and technology. Our purpose is to solve global problems in information processing, healthcare, energy and environment through the application of nanoscience and nanotechnology. Founded in 2003, the LCN is a joint venture between University College London and Imperial College London and based at the Bloomsbury and South Kensington sites.
For more information, please click here
London Centre for Nanotechnology
17-19 Gordon Street
London WC1H 0AH
tel: +44 (0)20 7679 0604
fax: +44 (0)20 7679 0595
Copyright © London Centre for NanotechnologyIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Stealth nanocapsules kill Chagas parasites in mouse models June 22nd, 2016
New nanoparticle technology developed to treat aggressive thyroid cancer: Platform designed to deliver nanotherapy effective in preclinical models of metastatic anaplastic thyroid cancer June 21st, 2016
Soft decoupling of organic molecules on metal June 23rd, 2016